183 related articles for article (PubMed ID: 35378058)
41. Novel anti-Acanthamoebic properties of raloxifene sulfonate/sulfamate derivatives.
Siddiqui R; El-Gamal MI; Sajeev S; Zaraei SO; Khan NA
Mol Biochem Parasitol; 2023 Dec; 256():111582. PubMed ID: 37562558
[TBL] [Abstract][Full Text] [Related]
42. Selected Gut Bacteria from Water Monitor Lizard Exhibit Effects against Pathogenic
Akbar N; Khan NA; Giddey AD; Soares NC; Alharbi AM; Alfahemi H; Siddiqui R
Microorganisms; 2023 Apr; 11(4):. PubMed ID: 37110494
[TBL] [Abstract][Full Text] [Related]
43. Antibiotic Effects of Loperamide: Homology of Human Targets of Loperamide with Targets in Acanthamoeba spp.
Baig AM; Rana Z; Mannan M; Tariq S; Ahmad HR
Recent Pat Antiinfect Drug Discov; 2017; 12(1):44-60. PubMed ID: 28506204
[TBL] [Abstract][Full Text] [Related]
44. Combating the causative agent of amoebic keratitis, Acanthamoeba castellanii, using Padina pavonica alcoholic extract: toxicokinetic and molecular docking approaches.
Abdel-Hakeem SS; Hassan FAM; Hifney AF; Salem SH
Sci Rep; 2024 Jun; 14(1):13610. PubMed ID: 38871751
[TBL] [Abstract][Full Text] [Related]
45. Anti-amoebic potential of azole scaffolds and nanoparticles against pathogenic Acanthamoeba.
Walvekar S; Anwar A; Anwar A; Sridewi N; Khalid M; Yow YY; Khan NA
Acta Trop; 2020 Nov; 211():105618. PubMed ID: 32628912
[TBL] [Abstract][Full Text] [Related]
46. Synthetic Dihydropyridines as Novel Antiacanthamoebic Agents.
Anwar A; Siddiqui R; Hameed A; Shah MR; Khan NA
Med Chem; 2020; 16(7):841-847. PubMed ID: 31544702
[TBL] [Abstract][Full Text] [Related]
47. In Vitro Amoebicidal Activity of Imidazolium Salts Against Trophozoites.
Fabres LF; da Costa Gonçalves F; Duarte EOS; Berté FK; da Conceição DKSL; Ferreira LA; Schrekker HS; Rott MB
Acta Parasitol; 2020 Jun; 65(2):317-326. PubMed ID: 31939031
[TBL] [Abstract][Full Text] [Related]
48. Antiamoebic Activity of Imidazothiazole Derivatives against Opportunistic Pathogen
Akbar N; El-Gamal MI; Saeed BQ; Oh CH; Abdel-Maksoud MS; Khan NA; Alharbi AM; Alfahemi H; Siddiqui R
Antibiotics (Basel); 2022 Aug; 11(9):. PubMed ID: 36139962
[TBL] [Abstract][Full Text] [Related]
49. Evidence of human-like Ca
Baig AM; Rana Z; Waliani N; Karim S; Rajabali M
Chem Biol Drug Des; 2019 Mar; 93(3):351-363. PubMed ID: 30362253
[TBL] [Abstract][Full Text] [Related]
50. Oleic acid-conjugated silver nanoparticles as efficient antiamoebic agent against Acanthamoeba castellanii.
Anwar A; Abdalla SAO; Aslam Z; Shah MR; Siddiqui R; Khan NA
Parasitol Res; 2019 Jul; 118(7):2295-2304. PubMed ID: 31093751
[TBL] [Abstract][Full Text] [Related]
51. In vitro evaluation of the effectiveness of the macrolide rokitamycin and chlorpromazine against Acanthamoeba castellanii.
Mattana A; Biancu G; Alberti L; Accardo A; Delogu G; Fiori PL; Cappuccinelli P
Antimicrob Agents Chemother; 2004 Dec; 48(12):4520-7. PubMed ID: 15561820
[TBL] [Abstract][Full Text] [Related]
52. THE USE OF EXTRACTS FROM PASSIFLORA SPP. IN HELPING THE TREATMENT OF ACANTHAMOEBIASIS.
Hadas E; Ozarowski M; Derda M; Thiem B; Cholewinski M; Skrzypczak L; Gryszczynska A; Piasecka A
Acta Pol Pharm; 2017 May; 74(3):921-928. PubMed ID: 29513962
[TBL] [Abstract][Full Text] [Related]
53. In vitro amoebicidal activity of propolis on Acanthamoeba castellanii.
Topalkara A; Vural A; Polat Z; Toker MI; Arici MK; Ozan F; Cetin A
J Ocul Pharmacol Ther; 2007 Feb; 23(1):40-5. PubMed ID: 17341149
[TBL] [Abstract][Full Text] [Related]
54. In vitro amoebicidal activity of ethanol extracts of Arachis hypogaea L., Curcuma longa L. and Pancratium maritimum L. on Acanthamoeba castellanii cysts.
El-Sayed NM; Ismail KA; Ahmed SA; Hetta MH
Parasitol Res; 2012 May; 110(5):1985-92. PubMed ID: 22146994
[TBL] [Abstract][Full Text] [Related]
55. Novel Anti-Acanthamoebic Activities of Irosustat and STX140 and Their Nanoformulations.
Siddiqui R; Rawas-Qalaji M; El-Gamal MI; Sajeev S; Jagal J; Zaraei SO; Sbenati RM; Anbar HS; Dohle W; Potter BVL; Khan NA
Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978428
[TBL] [Abstract][Full Text] [Related]
56. Antiamoebic properties of Methyltrioctylammonium chloride based deep eutectic solvents.
Siddiqui R; Makhlouf Z; Akbar N; Khamis M; Ibrahim T; Khan AS; Khan NA
Cont Lens Anterior Eye; 2023 Apr; 46(2):101758. PubMed ID: 36243521
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and application of statins as a novel effective therapeutic approach against Acanthamoeba infections.
Martín-Navarro CM; Lorenzo-Morales J; Machin RP; López-Arencibia A; García-Castellano JM; de Fuentes I; Loftus B; Maciver SK; Valladares B; Piñero JE
Antimicrob Agents Chemother; 2013 Jan; 57(1):375-81. PubMed ID: 23114753
[TBL] [Abstract][Full Text] [Related]
58. Potential anti-amoebic effects of synthetic 1,4-benzothiazine derivatives against
Alishba ; Ahmed U; Taha M; Khan NA; Salar U; Khan KM; Anwar A; Siddiqui R
Heliyon; 2024 Jan; 10(1):e23258. PubMed ID: 38205285
[TBL] [Abstract][Full Text] [Related]
59. Cytochrome P450 monooxygenase of Acanthamoeba castellanii participates in resistance to polyhexamethylene biguanide treatment.
Huang JM; Ko PJ; Huang CL; Wen PW; Chen CH; Shih MH; Lin WC; Huang FC
Parasite; 2021; 28():77. PubMed ID: 34762043
[TBL] [Abstract][Full Text] [Related]
60. In vitro amoebicidal activity of Salvia staminea and Salvia caespitosa on Acanthamoeba castellanii and their cytotoxic potentials on corneal cells.
Goze I; Alim A; Dag S; Tepe B; Polat ZA
J Ocul Pharmacol Ther; 2009 Aug; 25(4):293-8. PubMed ID: 19450152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
